Hematopoietic growth factors in the treatment of acquired aplastic anemia

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2008, Pages

  Gurion, Ronit ^a   Gafter Gvili, Anat ^a   Paul, Mical ^a   Vidal, Liat ^a   Ben Bassat, Isaac ^b   Yeshurun, Moshe ^a   Shpilberg, Ofer ^a   Raanani, Pia ^a  

^a RABIN MEDICAL CENTER   (Israel)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR; CORTICOSTEROID; CYCLOSPORIN A; ERYTHROPOIETIN; GRANULOCYTE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; PLACEBO; THYMOCYTE ANTIBODY;

APLASTIC ANEMIA; CLINICAL TRIAL; CLONE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MORTALITY; NEUTROPENIA; NEUTROPHIL COUNT; REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 55049120890     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007466     Document Type: Review

References (22)

1. Ades 2004 Ades L, Mary JY, Robin M, Ferry C, Porcher R, Esperou H, et al.Long term outcome after bone marrow transplantation for severe aplastic anemia. Blood 2004;103:2490-7.
2. Bacigalupo 1988 Bacigalupo A, Hows JM, Gluckman E, Nissen C, Marsh J, Van Lint MT, et al.Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anemia (SAA): a report of the EBMT SAA Working Party. British Journal of Haematology 1988;70:177-82.
3. Bacigalupo 1995 Bacigalupo A, Broccia G, Corda G, Arcese W, Carotenuto M, Gallamini A, et al.Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood 1995;85:1348-53.
4. Bacigalupo 2000 Bacigalupo A, Bruno B, Saracco P, Di Bona E, Locasciulli A, Locatelli F, et al.Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. Blood 2000;95:1931-34.
5. Brodskey 1998 Brodskey RA. Biology and management of acquired severe aplastic anemia. Current Opinion in Oncology 1998;10:95-99.
6. Camitta 1976 Camitta BM, Thomas ED, Nathan DG, et al.Severe aplastic anemia: a prospective study of the effect of early bonemarrow transplantation on acute mortality. Blood 1976;48:63-70.
7. David 1990 David HS. Use of hematopoietic growth factor for treatment of aplastic anemia. Am J Pediatr Hematol Oncol 1990;12:425.
8. Frickhofen 1991 Frickhofen N, Kaltwasser JP, Schredzenmeler H, et al.Treatment of aplastic anemia with antithymocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 1991;324:1297.
9. Gluckman 2002 Gluckman E, Milewska RR, Hann I, Nikiforakis E, Tavakoli F, Scali SC, et al.Results and follow-up of phase III randomized study of recombinant human-granulocyte stimulating factor as support for immunosuppressive therapy in patients with severe aplastic anemia. Br J Hem 2002;119:1075-82.
10. Greenberg 1996 Greenberg P, Negrin R, Ginzton N. G-CSF synergizes with erythropoietin (EPO) for enhancing colony formation (BFU-E) in myelodystrophic syndromes (MDS). Blood 1996;87:4076.
11. Higgins 2008 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. The Cochrane Collaboration, 2008.
12. Hord 1995 Hord JD, Gay JC, Whitlock JA, Janco RL, Edwards JR, Greer JP, et al.Long-term granulocyte-macrophage colony-stimulating factor and immunosuppression in the treatment of acquired severe aplastic anemia. J Pediatr Hematol Oncol 1995;17:140-4.
13. Issaragrisil 2006 Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, et al.Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS. The epidemiology of aplastic anemia in Thailand. Blood 2006;107:1299-307.
14. Kojima 2000 Kojima S, Hibi S, Kosaka Y, Yamamoto M, Tsuchida M, Mugishima H, et al.Immunosuppressive therapy using antithymocyte globulin, cyclosporine, and danazol with or without human granulocyte colony-stimulating factor in children with acquired aplastic anemia. Blood 2000;96:2049-54.
15. Kojima 2002 Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, et al.Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 2002;100:786-90.
16. Locasciulli 2001 Locasciulli A, Arcese W, Locatelli F, Di Bona E, Bacigalupo A. Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy. Italian Aplastic Anaemia Study Group. Lancet 2001;357:43-4.
17. Marsh 2003 Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, McCann SR, Mercieca J, Oscier D, Roques AW, Yin JA, British Committee for Standards in Haematology. Guidelines for the diagnosis and management of acquired aplastic anaemia. British Journal of Haematology 2003 Dec;123:782-801.
18. Mary 1990 Mary JY, Baumelou E, Guiguet M. Epidemiology of aplastic anemia in France: a prospective multicentric study. The French Cooperative Group for Epidemiological Study of Aplastic Anemia. Blood 1990;75:1646-53.
19. Rosenfeld 1995 Rosenfeld SE, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995;85:3058.
20. Storb 1992 Storb R, Longton G, Anasetti C, Appelbaum FR, Beatty P, Besinger W, Crawford S, et al.Changing trends in marrow transplantation for aplastic anemia. Bone Marrow Transplant. 1992;10 Suppl 1:45-52.
21. Young 1994 Young NS, Alter BP. Aplastic anemia : acquired and inherited. WB Saunnders, 1994.
22. Zheng 2006 Zheng Y, Liu Y, Chu Y. Immunosuppressive therapy for acquired severe aplastic anemia (SAA): A prospective comparison of four different regimens. Ext Hematol. 2006;34:826-31.